NYSE:EVH - Evolent Health Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $25.19 -0.02 (-0.08 %) (As of 11/13/2018 01:42 AM ET)Previous Close$25.19Today's Range$24.55 - $25.4752-Week Range$10.30 - $29.05Volume873,100 shsAverage Volume887,924 shsMarket Capitalization$1.98 billionP/E Ratio-36.01Dividend YieldN/ABeta1.5 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management. Its services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia. Receive EVH News and Ratings via Email Sign-up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Management services Sub-IndustryN/A SectorComputer and Technology Current SymbolNYSE:EVH Previous Symbol CUSIPN/A Webwww.evolenthealth.com Phone571-389-6000 Debt Debt-to-Equity Ratio0.12 Current Ratio2.59 Quick Ratio2.59 Price-To-Earnings Trailing P/E Ratio-36.01 Forward P/E Ratio-74.09 P/E GrowthN/A Sales & Book Value Annual Sales$434.95 million Price / Sales4.55 Cash FlowN/A Price / CashN/A Book Value$13.52 per share Price / Book1.86 Profitability EPS (Most Recent Fiscal Year)($0.70) Net Income$-60,660,000.00 Net Margins-9.05% Return on Equity-2.18% Return on Assets-1.75% Miscellaneous Employees2,600 Outstanding Shares78,640,000Market Cap$1.98 billion OptionableOptionable Evolent Health (NYSE:EVH) Frequently Asked Questions What is Evolent Health's stock symbol? Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH." How were Evolent Health's earnings last quarter? Evolent Health Inc (NYSE:EVH) posted its earnings results on Tuesday, November, 6th. The technology company reported ($0.04) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.11) by $0.07. The technology company had revenue of $150.16 million for the quarter, compared to the consensus estimate of $142.94 million. Evolent Health had a negative net margin of 9.05% and a negative return on equity of 2.18%. The business's quarterly revenue was up 38.6% on a year-over-year basis. During the same period in the prior year, the business posted ($0.18) earnings per share. View Evolent Health's Earnings History. When is Evolent Health's next earnings date? Evolent Health is scheduled to release their next quarterly earnings announcement on Tuesday, February 26th 2019. View Earnings Estimates for Evolent Health. What price target have analysts set for EVH? 11 brokers have issued 1 year price targets for Evolent Health's shares. Their predictions range from $25.00 to $37.00. On average, they anticipate Evolent Health's share price to reach $32.30 in the next year. This suggests a possible upside of 28.2% from the stock's current price. View Analyst Price Targets for Evolent Health. What is the consensus analysts' recommendation for Evolent Health? 11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Evolent Health. What are Wall Street analysts saying about Evolent Health stock? Here are some recent quotes from research analysts about Evolent Health stock: 1. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating on EVH shares and increase our price target to $37 from $28. This morning, EVH announced the acquisition of privately-held New Century Health (NCH). NCH manages approximately 462,000 Medicare Advantage lives for 12 long-term operating partners across multiple states. NCH’s customers include at-risk providers as well as national and regional health plans. We believe that the acquisition of NCH is very attractive financially and a very solid fit strategically. NCH basically doubles EVH’s adjusted EBITDA. Strategically, it looks like NCH operates a more mature" EVH business model. Overall, we believe the acquisition is a nice positive for EVH." (9/12/2018) 2. According to Zacks Investment Research, "Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. " (8/10/2018) Has Evolent Health been receiving favorable news coverage? Press coverage about EVH stock has been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Evolent Health earned a news impact score of 1.2 on InfoTrie's scale. They also gave news headlines about the technology company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. Who are some of Evolent Health's key competitors? Some companies that are related to Evolent Health include Servicemaster Global (SERV), Premier (PINC), Mantech International (MANT), R1 RCM (RCM), Franklin Covey (FC), Jupai (JP), PHI Group (PHIL) and Rainmaker Systems (VCTL). Who are Evolent Health's key executives? Evolent Health's management team includes the folowing people: Mr. Frank J. Williams, Co-Founder, CEO & Chairman (Age 51)Mr. Seth Blackley, Co-Founder, Pres & Director (Age 39)Mr. Thomas Peterson III, Co-Founder & COO (Age 48)Mr. Nicholas McGrane, Chief Financial Officer (Age 50)Ms. Lydia Stone, VP, Chief Accounting Officer & Controller (Age 42) When did Evolent Health IPO? (EVH) raised $150 million in an initial public offering (IPO) on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers. Who are Evolent Health's major shareholders? Evolent Health's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Bank of New York Mellon Corp (7.01%), BlackRock Inc. (5.81%), Riverbridge Partners LLC (4.36%), Eagle Asset Management Inc. (3.23%), FMR LLC (3.05%) and Elk Creek Partners LLC (1.99%). Company insiders that own Evolent Health stock include Board Co Advisory, Cheryl Scott, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Lydia Stone, Michael D'amato, Nicholas Mcgrane, Seth Blackley, Steve Wigginton, Thomas Peterson III, Tpg Growth Ii Advisors, Inc, Unitedhealth Group Inc and Upmc. View Institutional Ownership Trends for Evolent Health. Which institutional investors are selling Evolent Health stock? EVH stock was sold by a variety of institutional investors in the last quarter, including Gabelli Funds LLC, Riverbridge Partners LLC, Elk Creek Partners LLC, Peregrine Capital Management LLC, Bank of New York Mellon Corp, Prudential Financial Inc., Eagle Asset Management Inc. and Gamco Investors INC. ET AL. Company insiders that have sold Evolent Health company stock in the last year include Cheryl Scott, Frank J Williams, Jonathan Weinberg, Lydia Stone, Seth Blackley, Thomas Peterson III and Unitedhealth Group Inc. View Insider Buying and Selling for Evolent Health. Which institutional investors are buying Evolent Health stock? EVH stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Columbus Circle Investors, Oak Ridge Investments LLC, Monarch Partners Asset Management LLC, BlackRock Inc., Tygh Capital Management Inc., Chicago Capital LLC and EAM Investors LLC. View Insider Buying and Selling for Evolent Health. How do I buy shares of Evolent Health? Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Evolent Health's stock price today? One share of EVH stock can currently be purchased for approximately $25.19. How big of a company is Evolent Health? Evolent Health has a market capitalization of $1.98 billion and generates $434.95 million in revenue each year. The technology company earns $-60,660,000.00 in net income (profit) each year or ($0.70) on an earnings per share basis. Evolent Health employs 2,600 workers across the globe. What is Evolent Health's official website? The official website for Evolent Health is http://www.evolenthealth.com. How can I contact Evolent Health? Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000. MarketBeat Community Rating for Evolent Health (NYSE EVH)Community Ranking: 3.4 out of 5 ( )Outperform Votes: 368 (Vote Outperform)Underperform Votes: 180 (Vote Underperform)Total Votes: 548MarketBeat's community ratings are surveys of what our community members think about Evolent Health and other stocks. Vote "Outperform" if you believe EVH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/13/2018 by MarketBeat.com StaffFeatured Article: Asset Allocation Models, Which is Right For You?